Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jingjing You
Observed names:
J. You,
游靖靖
Institution:
First Affiliated Hospital of Jinan University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
First Affiliated Hospital of Jinan University,
Tianjin Medical University
ORCID:
0009-0005-4451-7487
Observed ORCID:
0009-0005-4451-7487
OpenAlex ID:
A5078876394
Artificial Intelligence Can Predict Personalized Immunotherapy Outcomes in Cancer
2025
·
Ling Huang
, Xuewei Wu
, et al.
·
Cancer Immunology Research
·
28
Radiomic Model Associated with Tumor Microenvironment Predicts Immunotherapy Response and Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
2025
·
Jie Sun
, Xuewei Wu
, et al.
·
Research
·
11
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy
2024
·
Xuewei Wu
, Jingjing You
, et al.
·
Journal for ImmunoTherapy of Cancer
·
4
PDF
120P Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
2023
·
Y. Chen
, B. Yan
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Studies on the role of ADAM17/MUC1-CT on TGF-β-induced enhancer of zeste homolog 2 expression in human lung fibroblasts
2021
·
游靖靖
, YOU, JING-JING
·
Taipei Medical University Repository
Show more works
View as search
Works count:
5
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type